Get the Stockscreener App
6.86
4.10%
0.27
Coya Therapeutics Inc stock is traded at $6.86, with a volume of 94,743.
It is up +4.10% in the last 24 hours and up +20.56% over the past month.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
See More
Previous Close:
$6.59
Open:
$6.71
24h Volume:
94,743
Relative Volume:
1.68
Market Cap:
$114.73M
Revenue:
-
Net Income/Loss:
$-14.88M
P/E Ratio:
-7.00
EPS:
-0.98
Net Cash Flow:
$-10.29M
1W Performance:
+11.54%
1M Performance:
+20.56%
6M Performance:
+7.02%
1Y Performance:
+10.29%
1-Day Range:
$6.49
$6.89
1-Week Range:
$5.86
$6.89
52-Week Range:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Name
Coya Therapeutics Inc
Sector
Industry
Phone
650.739.3939
Address
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Compare COYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
6.86 | 100.52M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | D. Boral Capital | Buy |
Coya Therapeutics Inc Stock (COYA) Latest News
How volatile is Coya Therapeutics Inc. stockPortfolio Growth Summary & Weekly High Conviction Ideas - newsyoung.net
Why Coya Therapeutics Inc. stock attracts strong analyst attentionRate Hike & Daily Technical Stock Forecast Reports - 선데이타임즈
Published on: 2025-08-16 02:30:48 - newsyoung.net
Regulatory Risk and Reward: Navigating FDA Delays in the ALS Therapeutics Landscape - AInvest
Coya Therapeutics reports Q2 EPS (36c), consensus (43c) - MSN
Coya Therapeutics 2025 Q2 Earnings Sharp Loss Widens, Revenue Collapses - AInvest
Coya Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Coya Therapeutics’ (COYA) Buy Rating Reaffirmed at D. Boral Capital - Defense World
Is Coya Therapeutics Inc. stock ready for a breakoutPortfolio Update Summary & Free Fast Gain Swing Trade Alerts - Newser
Coya Therapeutics, Inc. (COYA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Coya Therapeutics shares rise 2.46% after-hours after announcing participation in H.C. Wainwright 3rd Annual BioConnect Conference. - AInvest
Coya Therapeutics Inc. recovery potential after sell offStock Surge & Community Consensus Stock Picks - Newser
Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update - BioSpace
Coya Therapeutics Reports Increased Losses Amid Development Focus - TipRanks
Coya Therapeutics' $75M Mixed Shelf: Fueling Neuroinflammation Breakthroughs in ALS, Alzheimer's, and Dementia - AInvest
Coya Therapeutics Files $75 Million Mixed Shelf and Reports Q2 Earnings - AInvest
Coya Therapeutics Files $75 Million Mixed Shelf - MarketScreener
Coya Therapeutics Highlights Q2 2025 Financial Results - TipRanks
Coya Therapeutics, Inc. SEC 10-Q Report - TradingView
Is Coya Therapeutics Inc. trending in predictive chart modelsDay Trading Setup and Momentum Analysis - Newser
How Resilient Is Coya Therapeutics Inc. Stock During Economic DownturnsValue Holding Return Summary With Outlook - Newser
Using Python tools to backtest Coya Therapeutics Inc. strategiesReal-Time AI Generated Market Forecast - Newser
Sector ETF performance correlation with Coya Therapeutics Inc.Trading Watchlist with Real Time Filters - Newser
Tools to monitor Coya Therapeutics Inc. recovery probabilityConservative Equity Setup with Signal Analysis - Newser
Published on: 2025-08-11 07:24:51 - Newser
Understanding Coya Therapeutics Inc.’s price movementConservative Asset Allocation Risk Analysis - Newser
Intrinsic Value of Coya Therapeutics Inc. Stock: Is It Undervalued or OvervaluedAI Volatility Forecast and Risk Monitor - Newser
Coya Therapeutics COYA Q2 2025 Earnings Preview Upside Potential on Promising Product Pipeline - AInvest
How Coya Therapeutics Inc. stock performs during market volatilityTrade Plan With Low Risk High Return - Newser
What drives Coya Therapeutics Inc. stock priceLightning-fast capital gains - Jammu Links News
Does Coya Therapeutics Inc. stock perform well during market downturnsTrack top-performing stocks in real-time - Jammu Links News
How does Coya Therapeutics Inc. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? - MSN
Is it the right time to buy Coya Therapeutics Inc. stockGet daily updates on top-performing stocks - Jammu Links News
How many analysts rate Coya Therapeutics Inc. as a “Buy”Explosive earnings growth - Jammu Links News
How strong is Coya Therapeutics Inc. company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Coya Therapeutics Inc. stock higher in 2025Overwhelming financial success - Jammu Links News
What institutional investors are buying Coya Therapeutics Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
Is Coya Therapeutics Inc. a growth stock or a value stockTremendous growth opportunities - Jammu Links News
What are the technical indicators suggesting about Coya Therapeutics Inc.Get insider insights into market trends - Jammu Links News
What are Coya Therapeutics Inc. company’s key revenue driversCapitalize on emerging trends for profits - Jammu Links News
Should you wait for a breakout in Coya Therapeutics Inc.Free Top Gaining Picks With Entry Signals - Newser
How to manage a losing position in Coya Therapeutics Inc.Intraday Strategy with Real Time Monitoring - Newser
Applying Wyckoff theory to Coya Therapeutics Inc. stockFree AI Screening for Swing Trade Picks - Newser
Is Coya Therapeutics Inc. stock overvalued or undervaluedTop Growth Forecasts Backed By Experts - Jammu Links News
Coya Therapeutics Inc Stock (COYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Coya Therapeutics Inc Stock (COYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SNYDER DAVID S | Chief Financial Officer |
Nov 14 '24 |
Buy |
7.19 |
1,800 |
12,934 |
8,800 |
| Swaminathan Arun | Chief Executive Officer |
Nov 13 '24 |
Buy |
7.36 |
5,000 |
36,797 |
10,000 |
| Grossman Fred | Chief Medical Officer |
Nov 11 '24 |
Buy |
7.37 |
2,710 |
19,973 |
2,710 |
| Swaminathan Arun | Chief Executive Officer |
Nov 11 '24 |
Buy |
7.34 |
5,000 |
36,689 |
5,000 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):